The increased A2AR expression in RA lymphocytes is gradually reduced by anti-TNF-α agents like rituximab or MTX; however, in vitro stimulation with the receptor agonist CGS 21680 significantly increases IL-10 production [97]. Here, ADORA2A is linked to rheumatoid arthritis.